... Management Inc. purchased a new stake in CymaBay Therapeutics in the fourth quarter worth $115,000. Finally, Ardsley Advisory Partners grew its stake in CymaBay Therapeutics by 66.2% in the second quarter. Ardsley Advisory Partners now owns 50,210 ...
https://sportsperspectives.com/2018/02/13/cymabay-therapeutics-cbay-reaches-new-52-week-high-following-insider-buying-activity.html
No comments:
Post a Comment